Evidence map›Paper›PMID 8203460›Full record

ArticleThe American journal of pathology1994

Bcl-2 expression in normal endometrium during the menstrual cycle.

A Gompel, J C Sabourin, A Martin, H Yaneva, J Audouin, Y Decroix, P Poitout

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 151 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. BCL2 regulates neural differentiation.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

A GompelDepartement de Gynécologie et Obstétrique, Hôpital Hotel Dieu, Paris, France.
J C Sabourin
A Martin
H Yaneva
J Audouin
Y Decroix
P Poitout
Hôtel-Dieu de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bcl-2 is a proto-oncogene initially described in the (14;18) translocation in follicular lymphoma. It has been shown to prolong cell survival by preventing apoptosis. Endometrium undergoes rapid proliferation and differentiation under hormone control and is thus an excellent model to study the hormone dependency of Bcl-2 expression. We studied Bcl-2 expression by an immunohistochemical method in 53 samples of normal endometrium randomly distributed throughout the menstrual cycle, as well as five samples of hyperplastic endometrium. Bcl-2 staining predominated in glandular cells and peaked at the end of the follicular phase. Bcl-2 expression disappeared at the onset of secretory activity. The stroma, surface lining epithelium and arterial vessels also displayed cyclic variations in Bcl-2 expression. These results strongly suggest hormone-dependent regulation of Bcl-2 expression, which could play an important role in tumorigenesis.

Indexed as

AdultCell DivisionEndometriumFemaleFollicular PhaseHumansHyperplasiaImmunohistochemistryKi-67 AntigenLuteal PhaseMenstrual CycleMiddle AgedMyometriumNeoplasm ProteinsNuclear ProteinsProto-Oncogene MasKi-67 AntigenMAS1 protein, humanNeoplasm ProteinsNuclear ProteinsProto-Oncogene MasProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID8203460
PMCPMC1887458
OpenAlexW5304649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.